logo

For the Inventor, By the Inventor

Xiamen, China

Ting Zhang

This inventor holds 5 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Xiamen University, Boston University. Active years: 2019-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ting Zhang. Retrieved from https://idiyas.com/inventor/ting-zhang-egpe4p0v

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 5 

% Patents Active = 100.0

 

Average Co-Inventor Count = 7.2

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Fujian, CN (2019)
  • Xiamen, CN (2022 - 2023)

Company Filing History:

goldMedal5 out of 165 
 
Xiamen University
 patents
silverMedal1 out of 833 
 
Boston University
 patents
where one patent can have more than one assignee

Years Active: 2019-2023

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents
1. 11542240 - STK19 inhibitors for treatment of cancer (2023-01-03),
2. 11352354 - Substituted penta-fused hexa-heterocyclic compounds, preparation method therefor, drug combination and use thereof (2022-06-07),
3. 11319322 - Substituted aryl ether compound, preparation method thereof, pharmaceutical composition and use thereof (2022-05-03),
4. 11292787 - Five-membered-fused-six-membered aza-aromatic ring compound, preparation method thereof, pharmaceutical composition and application thereof (2022-04-05),
5. 10508118 - Pyrimidopyrrole compounds, method for preparing the same, pharmaceutical compositions comprising the same and uses thereof (2019-12-17),

Title: Innovations and Contributions of Inventor Ting Zhang

Introduction

Ting Zhang is a notable inventor based in Xiamen, China. He has made significant contributions to the field of cancer treatment through his innovative research and development of new pharmaceutical compounds. With a total of 5 patents, his work has the potential to impact the medical community significantly.

Latest Patents

Among his latest patents, Ting Zhang has developed STK19 inhibitors for the treatment of cancer. This patent includes compositions and methods aimed at the treatment and prevention of various cancers, including melanoma. Another significant patent involves substituted penta-fused hexa-heterocyclic compounds, which have selective inhibition for PIKfyve kinase. This patent outlines a method for the preparation of these compounds, their pharmaceutical compositions, and their use in manufacturing medicaments for preventing or treating diseases associated with PIKfyve, particularly in relation to tumor growth and metastasis.

Career Highlights

Ting Zhang has worked at prestigious institutions such as Xiamen University and Boston University. His research has focused on developing innovative solutions for complex medical challenges, particularly in oncology. His dedication to advancing cancer treatment through scientific research is commendable.

Collaborations

Ting Zhang has collaborated with esteemed colleagues, including Xianming Deng and Qingyan Xu. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.

Conclusion

Ting Zhang's contributions to cancer treatment through his innovative patents and collaborations highlight his role as a leading inventor in the field. His work continues to pave the way for advancements in medical science and patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…